M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma

Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor‐associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We co...

Full description

Saved in:
Bibliographic Details
Published inCancer science Vol. 114; no. 12; pp. 4521 - 4534
Main Authors Sumitomo, Ryota, Menju, Toshi, Shimazu, Yumeta, Toyazaki, Toshiya, Chiba, Naohisa, Miyamoto, Hideaki, Hirayama, Yutaka, Nishikawa, Shigeto, Tanaka, Satona, Yutaka, Yojiro, Yamada, Yoshito, Nakajima, Daisuke, Ohsumi, Akihiro, Hamaji, Masatsugu, Sato, Atsuyasu, Yoshizawa, Akihiko, Huang, Cheng‐Long, Haga, Hironori, Date, Hiroshi
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.12.2023
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor‐associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1‐like and M2‐like TAM distribution and EMT by E‐cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC‐1) and a human monocyte cell line (THP‐1) were used for in vitro experiments. M2‐like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E‐cadherin‐positive and 44 (19.9%) were vimentin‐positive. M2‐like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF‐β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF‐β1 secretion from TAMs was confirmed by ELISA. TAM‐co‐cultured H226 and EBC‐1 cells exhibited EMT (decreased E‐cadherin, increased vimentin). Regarding EMT‐activating transcriptional factors, phosphorylated Smad3 and ZEB‐family proteins were higher in TAM‐co‐cultured LUSC cells than in parental cells. TAM‐co‐cultured H226 and EBC‐1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC. TAM‐co‐cultured LUSC cells exhibited EMT through the TGF‐beta/Smad/ZEB pathway. TAM‐co‐cultured LUSC cells demonstrated enhanced migration and invasion capabilities and increased tumor cell proliferation.
AbstractList Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1-like and M2-like TAM distribution and EMT by E-cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC-1) and a human monocyte cell line (THP-1) were used for in vitro experiments. M2-like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E-cadherin-positive and 44 (19.9%) were vimentin-positive. M2-like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF-β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF-β1 secretion from TAMs was confirmed by ELISA. TAM-co-cultured H226 and EBC-1 cells exhibited EMT (decreased E-cadherin, increased vimentin). Regarding EMT-activating transcriptional factors, phosphorylated Smad3 and ZEB-family proteins were higher in TAM-co-cultured LUSC cells than in parental cells. TAM-co-cultured H226 and EBC-1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC.
Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor‐associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1‐like and M2‐like TAM distribution and EMT by E‐cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC‐1) and a human monocyte cell line (THP‐1) were used for in vitro experiments. M2‐like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E‐cadherin‐positive and 44 (19.9%) were vimentin‐positive. M2‐like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF‐β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF‐β1 secretion from TAMs was confirmed by ELISA. TAM‐co‐cultured H226 and EBC‐1 cells exhibited EMT (decreased E‐cadherin, increased vimentin). Regarding EMT‐activating transcriptional factors, phosphorylated Smad3 and ZEB‐family proteins were higher in TAM‐co‐cultured LUSC cells than in parental cells. TAM‐co‐cultured H226 and EBC‐1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC. TAM‐co‐cultured LUSC cells exhibited EMT through the TGF‐beta/Smad/ZEB pathway. TAM‐co‐cultured LUSC cells demonstrated enhanced migration and invasion capabilities and increased tumor cell proliferation.
Epithelial-mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1-like and M2-like TAM distribution and EMT by E-cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC-1) and a human monocyte cell line (THP-1) were used for in vitro experiments. M2-like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E-cadherin-positive and 44 (19.9%) were vimentin-positive. M2-like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF-β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF-β1 secretion from TAMs was confirmed by ELISA. TAM-co-cultured H226 and EBC-1 cells exhibited EMT (decreased E-cadherin, increased vimentin). Regarding EMT-activating transcriptional factors, phosphorylated Smad3 and ZEB-family proteins were higher in TAM-co-cultured LUSC cells than in parental cells. TAM-co-cultured H226 and EBC-1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC.Epithelial-mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1-like and M2-like TAM distribution and EMT by E-cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC-1) and a human monocyte cell line (THP-1) were used for in vitro experiments. M2-like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E-cadherin-positive and 44 (19.9%) were vimentin-positive. M2-like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF-β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF-β1 secretion from TAMs was confirmed by ELISA. TAM-co-cultured H226 and EBC-1 cells exhibited EMT (decreased E-cadherin, increased vimentin). Regarding EMT-activating transcriptional factors, phosphorylated Smad3 and ZEB-family proteins were higher in TAM-co-cultured LUSC cells than in parental cells. TAM-co-cultured H226 and EBC-1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC.
Author Sumitomo, Ryota
Yutaka, Yojiro
Hamaji, Masatsugu
Huang, Cheng‐Long
Haga, Hironori
Toyazaki, Toshiya
Chiba, Naohisa
Yoshizawa, Akihiko
Miyamoto, Hideaki
Shimazu, Yumeta
Nakajima, Daisuke
Nishikawa, Shigeto
Tanaka, Satona
Sato, Atsuyasu
Ohsumi, Akihiro
Yamada, Yoshito
Menju, Toshi
Date, Hiroshi
Hirayama, Yutaka
AuthorAffiliation 2 Department of Thoracic Surgery Tazuke Kofukai Medical Research Institute, Kitano Hospital Osaka Japan
3 Department of Respiratory Medicine, Graduate School of Medicine Kyoto University Kyoto Japan
1 Department of Thoracic Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
4 Department of Diagnostic Pathology Kyoto University Hospital Kyoto Japan
AuthorAffiliation_xml – name: 3 Department of Respiratory Medicine, Graduate School of Medicine Kyoto University Kyoto Japan
– name: 1 Department of Thoracic Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
– name: 2 Department of Thoracic Surgery Tazuke Kofukai Medical Research Institute, Kitano Hospital Osaka Japan
– name: 4 Department of Diagnostic Pathology Kyoto University Hospital Kyoto Japan
Author_xml – sequence: 1
  givenname: Ryota
  orcidid: 0000-0002-1676-1571
  surname: Sumitomo
  fullname: Sumitomo, Ryota
  organization: Tazuke Kofukai Medical Research Institute, Kitano Hospital
– sequence: 2
  givenname: Toshi
  surname: Menju
  fullname: Menju, Toshi
  email: toshimnj@kuhp.kyoto‐u.ac.jp
  organization: Kyoto University
– sequence: 3
  givenname: Yumeta
  surname: Shimazu
  fullname: Shimazu, Yumeta
  organization: Kyoto University
– sequence: 4
  givenname: Toshiya
  surname: Toyazaki
  fullname: Toyazaki, Toshiya
  organization: Kyoto University
– sequence: 5
  givenname: Naohisa
  surname: Chiba
  fullname: Chiba, Naohisa
  organization: Kyoto University
– sequence: 6
  givenname: Hideaki
  surname: Miyamoto
  fullname: Miyamoto, Hideaki
  organization: Kyoto University
– sequence: 7
  givenname: Yutaka
  surname: Hirayama
  fullname: Hirayama, Yutaka
  organization: Kyoto University
– sequence: 8
  givenname: Shigeto
  surname: Nishikawa
  fullname: Nishikawa, Shigeto
  organization: Kyoto University
– sequence: 9
  givenname: Satona
  surname: Tanaka
  fullname: Tanaka, Satona
  organization: Kyoto University
– sequence: 10
  givenname: Yojiro
  surname: Yutaka
  fullname: Yutaka, Yojiro
  organization: Kyoto University
– sequence: 11
  givenname: Yoshito
  surname: Yamada
  fullname: Yamada, Yoshito
  organization: Kyoto University
– sequence: 12
  givenname: Daisuke
  surname: Nakajima
  fullname: Nakajima, Daisuke
  organization: Kyoto University
– sequence: 13
  givenname: Akihiro
  surname: Ohsumi
  fullname: Ohsumi, Akihiro
  organization: Kyoto University
– sequence: 14
  givenname: Masatsugu
  surname: Hamaji
  fullname: Hamaji, Masatsugu
  organization: Kyoto University
– sequence: 15
  givenname: Atsuyasu
  surname: Sato
  fullname: Sato, Atsuyasu
  organization: Kyoto University
– sequence: 16
  givenname: Akihiko
  surname: Yoshizawa
  fullname: Yoshizawa, Akihiko
  organization: Kyoto University Hospital
– sequence: 17
  givenname: Cheng‐Long
  surname: Huang
  fullname: Huang, Cheng‐Long
  organization: Tazuke Kofukai Medical Research Institute, Kitano Hospital
– sequence: 18
  givenname: Hironori
  surname: Haga
  fullname: Haga, Hironori
  organization: Kyoto University Hospital
– sequence: 19
  givenname: Hiroshi
  surname: Date
  fullname: Date, Hiroshi
  organization: Kyoto University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37806311$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1u1DAUhQMqoj-w6AsgS2xgMR3np3G8QtWIP6mIRbu3bpybiUtsp7bDMKz6CEi8CQ_CQ_RJcGamCCrIxrF9zsl3o3OY7BlrMEmOU3qSxmcuwZ-kp7xiD5ODNC_4jFFa7m3e2YzTPNtPDr2_ojQvC148TvZzVtEyT9ODB8cfstubb736hCSM2rq4Ae-tVBCwIRqks0MHS_RkcFbbgAQHFTrsFfS3N981ejSyW2voSXBgvArKGhI6Z8dlF1fcHrfWaWWWZOnsKnSkBRmsIz9_zC80NPOvykjSxnt0BCNBbb-QWplmcnRWo50OBgjdCtZkFT9PosEh-AkRA_gAQUkyRDwTIhgB02zHIRL7fkLvVYsONnDKkH6Myf56BG1Hv9VIcFIZq-FJ8qiF3uPT3XqUXL55fbl4Nzv_-Pb94ux8JouyYrMaaZ0i5azOMsY4AAPanFYty9OiLKAomjzlsuKQlWXL26ylVV1mWOdReMrr_Ch5tY0dxlpjIyO5g14MTmlwa2FBib9vjOrE0n4WKWVZRVMaE17sEpy9HtEHoZWfZgGDcSyRVayockZzFqXP70mv7OhMHE9ksR-UF7zkUfXsT6TfLHdtiYL5VhBb4b3DVkgVNj81Eqo-oompjyL2UWz6GB0v7znuQv-l3aWvVI_r_wvF4uxi6_gFtS_9Hw
CitedBy_id crossref_primary_10_1002_cam4_70670
crossref_primary_10_1007_s00262_025_03960_1
crossref_primary_10_1016_j_tranon_2025_102324
crossref_primary_10_3389_fphar_2024_1404687
crossref_primary_10_1016_j_imlet_2025_106970
crossref_primary_10_1016_j_intimp_2024_113811
crossref_primary_10_2174_0113892037315736240907131856
crossref_primary_10_3390_ijms25031857
crossref_primary_10_1080_17435390_2024_2314473
crossref_primary_10_1016_j_ejro_2024_100563
Cites_doi 10.1016/S0140-6736(16)30958-8
10.1088/1758-5090/aaafbc
10.1056/NEJMoa1501824
10.1016/j.lungcan.2019.08.023
10.3892/or.2022.8284
10.1038/nm0798-844
10.3389/fonc.2022.911410
10.1038/nrm3758
10.1186/s12935-018-0620-1
10.3390/cancers13164122
10.1016/j.lungcan.2022.11.015
10.1016/j.cell.2016.06.028
10.1186/s12964-020-00557-2
10.1186/s12865-018-0241-4
10.3892/or.2022.8282
10.1186/s13046-018-0981-2
10.1007/s11748-021-01595-4
10.1002/cam4.556
10.18632/oncotarget.9079
10.1186/s13046-020-01808-3
10.1186/s12885-022-10210-5
10.1186/s13046-021-02222-z
10.1073/pnas.1707929115
10.3389/fonc.2023.1110440
10.1126/scitranslmed.aax6337
10.1158/0008-5472.CAN-18-2052
10.1007/978-3-319-40618-3
10.3390/cells9051303
10.3892/ijo.2015.2861
10.1016/j.lungcan.2018.12.001
10.3892/or.2018.6657
10.1200/JCO.2005.02.2871
10.21873/anticanres.14311
10.3390/molecules24010009
10.1038/cr.2009.5
10.1186/s12964-020-00646-2
10.3892/etm.2019.8068
10.1158/1078-0432.CCR-11-2370
10.1002/1878-0261.12606
10.3892/or.2022.8404
10.1038/s41597-023-02074-6
10.2147/CMAR.S200819
ContentType Journal Article
Copyright 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
– notice: 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1111/cas.15987
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE - Academic
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Sumitomo et al
EISSN 1349-7006
EndPage 4534
ExternalDocumentID PMC10728010
37806311
10_1111_cas_15987
CAS15987
Genre researchArticle
Journal Article
GrantInformation_xml – fundername: Japan Society for the Promotion of Science
  funderid: 20H03770
– fundername: Japan Society for the Promotion of Science
  grantid: 20H03770
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
24P
29B
2WC
31~
36B
3O-
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
88E
8FE
8FH
8FI
8FJ
8UM
930
A01
A03
AAFWJ
AAMMB
AAZKR
ABCQN
ABEML
ABUWG
ACCMX
ACSCC
ACXQS
ADBBV
ADKYN
ADPDF
ADZMN
AEFGJ
AENEX
AFBPY
AFEBI
AFFNX
AFKRA
AFPKN
AFZJQ
AGXDD
AIDQK
AIDYY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BFHJK
BHPHI
BY8
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DR2
DU5
E3Z
EBS
EJD
EMB
EMOBN
EX3
F00
F01
F04
F5P
FIJ
FYUFA
GODZA
GROUPED_DOAJ
HCIFZ
HF~
HMCUK
HOLLA
HYE
HZI
HZ~
IAO
IHR
ITC
IX1
J0M
K.9
K48
KQ8
LC2
LC3
LH4
LK8
LP6
LP7
LW6
M1P
M7P
MK4
N04
N05
N9A
O9-
OIG
OK1
OVD
P2P
P2X
P2Z
P4B
P4D
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PROAC
PSQYO
Q11
ROL
RPM
RX1
SJN
SUPJJ
SV3
TEORI
UB1
UKHRP
W8V
WIN
WOW
WQJ
WXI
X7M
XG1
ZXP
~IA
~WT
AAHHS
AAYXX
ACCFJ
ADZOD
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
NPM
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c4687-be0b1e097b22779aa7a0d58f731464a44d319c89a266f9f2f08b62eb3a7a59b3
IEDL.DBID 7X7
ISSN 1347-9032
1349-7006
IngestDate Thu Aug 21 18:37:37 EDT 2025
Mon Jul 21 10:16:28 EDT 2025
Wed Aug 13 11:32:35 EDT 2025
Mon Jul 21 06:06:34 EDT 2025
Tue Jul 01 01:31:17 EDT 2025
Thu Apr 24 22:58:54 EDT 2025
Wed Aug 20 07:27:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords tumor-associated macrophage
epithelial-mesenchymal transition
vimentin
E-cadherin
lung squamous cell carcinoma
Language English
License Attribution-NonCommercial
2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4687-be0b1e097b22779aa7a0d58f731464a44d319c89a266f9f2f08b62eb3a7a59b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1676-1571
OpenAccessLink https://www.proquest.com/docview/2903094969?pq-origsite=%requestingapplication%
PMID 37806311
PQID 2903094969
PQPubID 4378882
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10728010
proquest_miscellaneous_2874837037
proquest_journals_2903094969
pubmed_primary_37806311
crossref_citationtrail_10_1111_cas_15987
crossref_primary_10_1111_cas_15987
wiley_primary_10_1111_cas_15987_CAS15987
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2023
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: December 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Tokyo
– name: Hoboken
PublicationTitle Cancer science
PublicationTitleAlternate Cancer Sci
PublicationYear 2023
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2015; 35
2021; 69
2023; 10
2023; 13
2015; 4
2020; 40
2019; 11
2019; 79
2022; 47
2016; 166
2019; 18
2020; 14
2022; 48
2012; 18
2022; 41
2018; 40
2020; 12
2019; 128
2022; 22
2005; 23
2018; 24
2020; 18
2015; 372
2015; 46
2018; 19
2021; 13
2018; 18
2016; 7
2023; 175
2018; 115
2020; 9
2022; 12
2014; 15
2019; 136
2017
2015
2009; 19
2018; 10
2017; 389
1998; 4
2021; 40
2018; 37
e_1_2_11_10_1
Attramadal CG (e_1_2_11_29_1) 2015; 35
e_1_2_11_32_1
e_1_2_11_31_1
e_1_2_11_30_1
e_1_2_11_36_1
e_1_2_11_14_1
e_1_2_11_13_1
e_1_2_11_35_1
e_1_2_11_12_1
e_1_2_11_34_1
e_1_2_11_11_1
Travis WD (e_1_2_11_25_1) 2015
e_1_2_11_33_1
e_1_2_11_7_1
e_1_2_11_6_1
e_1_2_11_28_1
e_1_2_11_5_1
e_1_2_11_27_1
e_1_2_11_4_1
e_1_2_11_26_1
e_1_2_11_3_1
e_1_2_11_2_1
e_1_2_11_21_1
e_1_2_11_44_1
e_1_2_11_20_1
e_1_2_11_45_1
e_1_2_11_40_1
e_1_2_11_24_1
e_1_2_11_41_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_42_1
e_1_2_11_8_1
e_1_2_11_22_1
e_1_2_11_43_1
e_1_2_11_18_1
e_1_2_11_17_1
e_1_2_11_16_1
e_1_2_11_15_1
e_1_2_11_37_1
e_1_2_11_38_1
e_1_2_11_39_1
e_1_2_11_19_1
References_xml – volume: 19
  start-page: 3
  year: 2018
  article-title: Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non‐small cell lung cancer
  publication-title: BMC Immunol
– volume: 11
  start-page: 3419
  year: 2019
  end-page: 3432
  article-title: Statins may have double‐edged effects in patients with lung adenocarcinoma after lung resection
  publication-title: Cancer Manag Res
– volume: 13
  year: 2023
  article-title: The role of targeted therapy and immune therapy in the management of non‐small cell lung cancer brain metastases
  publication-title: Front Oncol
– volume: 389
  start-page: 299
  year: 2017
  end-page: 311
  article-title: Lung cancer: current therapies and new targeted treatments
  publication-title: Lancet
– volume: 18
  start-page: 120
  year: 2018
  article-title: Tumor‐associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck
  publication-title: Cancer Cell Int
– volume: 9
  start-page: 1303
  year: 2020
  article-title: Lung tumor cell‐derived exosomes promote M2 macrophage polarization
  publication-title: Cell
– volume: 175
  start-page: 36
  year: 2023
  end-page: 46
  article-title: A novel cell‐based assay for the high‐throughput screening of epithelial‐mesenchymal transition inhibitors: identification of approved and investigational drugs that inhibit epithelial‐mesenchymal transition
  publication-title: Lung Cancer
– volume: 46
  start-page: 1844
  year: 2015
  end-page: 1848
  article-title: Critical contribution of MCL‐1 in EMT‐associated chemo‐resistance in A549 non‐small cell lung cancer
  publication-title: Int J Oncol
– volume: 22
  start-page: 1208
  year: 2022
  article-title: Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p‐AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma
  publication-title: BMC Cancer
– volume: 18
  start-page: 2443
  year: 2012
  end-page: 2451
  article-title: Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities
  publication-title: Clin Cancer Res
– volume: 41
  start-page: 10
  year: 2022
  article-title: M1‐like tumor‐associated macrophages cascade a mesenchymal/stem‐like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop
  publication-title: J Exp Clin Cancer Res
– volume: 115
  start-page: E2801
  year: 2018
  end-page: E2810
  article-title: Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition
  publication-title: Proc Natl Acad Sci USA
– volume: 47
  start-page: 73
  year: 2022
  article-title: Differential expression of PD‐L1 and PD‐L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non‐small cell lung cancer
  publication-title: Oncol Rep
– volume: 47
  start-page: 71
  year: 2022
  article-title: Inhibition of the VEGF signaling pathway attenuates tumor‐associated macrophage activity in liver cancer
  publication-title: Oncol Rep
– volume: 35
  start-page: 6111
  year: 2015
  end-page: 6120
  article-title: Tumor budding, EMT and cancer stem cells in T1‐2/N0 Oral squamous cell carcinomas
  publication-title: Anticancer Res
– volume: 40
  start-page: 13
  year: 2021
  article-title: Promotion of epithelial‐mesenchymal transformation by hepatocellular carcinoma‐educated macrophages through Wnt2b/β‐catenin/c‐Myc signaling and reprogramming glycolysis
  publication-title: J Exp Clin Cancer Res
– volume: 12
  year: 2020
  article-title: Mannose receptor (CD206) activation in tumor‐associated macrophages enhances adaptive and innate antitumor immune responses
  publication-title: Sci Transl Med
– volume: 128
  start-page: 13
  year: 2019
  end-page: 19
  article-title: Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial‐mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma
  publication-title: Lung Cancer
– volume: 37
  start-page: 307
  year: 2018
  article-title: The epithelial‐to‐mesenchymal transition induced by tumor‐associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
  publication-title: J Exp Clin Cancer Res
– volume: 372
  start-page: 2018
  year: 2015
  end-page: 2028
  article-title: Pembrolizumab for the treatment of non‐small‐cell lung cancer
  publication-title: N Engl J Med
– volume: 166
  start-page: 21
  year: 2016
  end-page: 45
  article-title: EMT: 2016
  publication-title: Cell
– volume: 14
  start-page: 462
  year: 2020
  end-page: 483
  article-title: Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β‐catenin signaling
  publication-title: Mol Oncol
– volume: 69
  start-page: 781
  year: 2021
  end-page: 789
  article-title: Lung cancer and epithelial‐mesenchymal transition
  publication-title: Gen Thorac Cardiovasc Surg
– volume: 79
  start-page: 1658
  year: 2019
  end-page: 1670
  article-title: Epithelial‐to‐mesenchymal transition is a mechanism of ALK inhibitor resistance in lung cancer independent of ALK mutation status
  publication-title: Cancer Res
– volume: 13
  start-page: 4122
  year: 2021
  article-title: Esophageal cancer‐derived extracellular vesicle miR‐21‐5p contributes to EMT of ESCC cells by disorganizing macrophage polarization
  publication-title: Cancers (Basel)
– volume: 24
  start-page: 9
  year: 2018
  article-title: Molecular repolarisation of tumour‐associated macrophages
  publication-title: Molecules
– volume: 12
  year: 2022
  article-title: Progress of tumor‐associated macrophages in the epithelial‐mesenchymal transition of tumor
  publication-title: Front Oncol
– volume: 7
  start-page: 34217
  year: 2016
  end-page: 34228
  article-title: Prognostic impact of tumor‐associated macrophage infiltration in non‐small cell lung cancer: a systemic review and meta‐analysis
  publication-title: Oncotarget
– volume: 40
  start-page: 3287
  year: 2020
  end-page: 3296
  article-title: Tranilast inhibits TGF‐β1‐induced epithelial‐mesenchymal transition and invasion/metastasis via the suppression of Smad4 in human lung cancer cell lines
  publication-title: Anticancer Res
– volume: 23
  start-page: 8765
  year: 2005
  end-page: 8773
  article-title: Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor–An expression in non‐small‐cell lung cancer
  publication-title: J Clin Oncol
– volume: 4
  start-page: 844
  year: 1998
  end-page: 847
  article-title: Tissue microarrays for high‐throughput molecular profiling of tumor specimens
  publication-title: Nat Med
– volume: 18
  start-page: 51
  year: 2020
  article-title: Wnt5a‐induced M2 polarization of tumor‐associated macrophages via IL‐10 promotes colorectal cancer progression
  publication-title: Cell Commun Signal
– volume: 15
  start-page: 178
  year: 2014
  end-page: 196
  article-title: Molecular mechanisms of epithelial‐mesenchymal transition
  publication-title: Nat Rev Mol Cell Biol
– volume: 4
  start-page: 1853
  year: 2015
  end-page: 1862
  article-title: Association between epithelial‐mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma
  publication-title: Cancer Med
– volume: 19
  start-page: 156
  year: 2009
  end-page: 172
  article-title: TGF‐beta‐induced epithelial to mesenchymal transition
  publication-title: Cell Res
– year: 2017
– volume: 10
  year: 2018
  article-title: Matrix stiffness and tumor‐associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells
  publication-title: Biofabrication
– volume: 18
  start-page: 143
  year: 2020
  article-title: Non‐canonical Fzd7 signaling contributes to breast cancer mesenchymal‐like stemness involving Col6a1
  publication-title: Cell Commun Signal
– volume: 10
  start-page: 167
  year: 2023
  article-title: An integrated single‐cell transcriptomic dataset for non‐small cell lung cancer
  publication-title: Sci Data
– volume: 136
  start-page: 136
  year: 2019
  end-page: 144
  article-title: PD‐L1 expression on tumor‐infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non‐small cell lung cancer
  publication-title: Lung Cancer
– volume: 40
  start-page: 2558
  year: 2018
  end-page: 2572
  article-title: Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma
  publication-title: Oncol Rep
– year: 2015
– volume: 18
  start-page: 4490
  year: 2019
  end-page: 4498
  article-title: M2 tumor‐associated macrophages promote tumor progression in non‐small‐cell lung cancer
  publication-title: Exp Ther Med
– volume: 48
  start-page: 189
  year: 2022
  article-title: Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non‐small cell lung cancer
  publication-title: Oncol Rep
– ident: e_1_2_11_5_1
  doi: 10.1016/S0140-6736(16)30958-8
– ident: e_1_2_11_18_1
  doi: 10.1088/1758-5090/aaafbc
– ident: e_1_2_11_4_1
  doi: 10.1056/NEJMoa1501824
– ident: e_1_2_11_7_1
  doi: 10.1016/j.lungcan.2019.08.023
– ident: e_1_2_11_8_1
  doi: 10.3892/or.2022.8284
– ident: e_1_2_11_26_1
  doi: 10.1038/nm0798-844
– ident: e_1_2_11_12_1
  doi: 10.3389/fonc.2022.911410
– ident: e_1_2_11_14_1
  doi: 10.1038/nrm3758
– ident: e_1_2_11_21_1
  doi: 10.1186/s12935-018-0620-1
– ident: e_1_2_11_20_1
  doi: 10.3390/cancers13164122
– ident: e_1_2_11_45_1
  doi: 10.1016/j.lungcan.2022.11.015
– ident: e_1_2_11_15_1
  doi: 10.1016/j.cell.2016.06.028
– ident: e_1_2_11_34_1
  doi: 10.1186/s12964-020-00557-2
– ident: e_1_2_11_10_1
  doi: 10.1186/s12865-018-0241-4
– ident: e_1_2_11_30_1
  doi: 10.3892/or.2022.8282
– ident: e_1_2_11_38_1
  doi: 10.1186/s13046-018-0981-2
– ident: e_1_2_11_36_1
  doi: 10.1007/s11748-021-01595-4
– volume-title: WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart
  year: 2015
  ident: e_1_2_11_25_1
– ident: e_1_2_11_27_1
  doi: 10.1002/cam4.556
– ident: e_1_2_11_9_1
  doi: 10.18632/oncotarget.9079
– ident: e_1_2_11_32_1
  doi: 10.1186/s13046-020-01808-3
– ident: e_1_2_11_19_1
  doi: 10.1186/s12885-022-10210-5
– ident: e_1_2_11_23_1
  doi: 10.1186/s13046-021-02222-z
– volume: 35
  start-page: 6111
  year: 2015
  ident: e_1_2_11_29_1
  article-title: Tumor budding, EMT and cancer stem cells in T1‐2/N0 Oral squamous cell carcinomas
  publication-title: Anticancer Res
– ident: e_1_2_11_42_1
  doi: 10.1073/pnas.1707929115
– ident: e_1_2_11_3_1
  doi: 10.3389/fonc.2023.1110440
– ident: e_1_2_11_41_1
  doi: 10.1126/scitranslmed.aax6337
– ident: e_1_2_11_40_1
  doi: 10.1158/0008-5472.CAN-18-2052
– ident: e_1_2_11_24_1
  doi: 10.1007/978-3-319-40618-3
– ident: e_1_2_11_31_1
  doi: 10.3390/cells9051303
– ident: e_1_2_11_39_1
  doi: 10.3892/ijo.2015.2861
– ident: e_1_2_11_13_1
  doi: 10.1016/j.lungcan.2018.12.001
– ident: e_1_2_11_22_1
  doi: 10.3892/or.2018.6657
– ident: e_1_2_11_37_1
  doi: 10.1200/JCO.2005.02.2871
– ident: e_1_2_11_43_1
  doi: 10.21873/anticanres.14311
– ident: e_1_2_11_11_1
  doi: 10.3390/molecules24010009
– ident: e_1_2_11_16_1
  doi: 10.1038/cr.2009.5
– ident: e_1_2_11_17_1
  doi: 10.1186/s12964-020-00646-2
– ident: e_1_2_11_6_1
  doi: 10.3892/etm.2019.8068
– ident: e_1_2_11_2_1
  doi: 10.1158/1078-0432.CCR-11-2370
– ident: e_1_2_11_33_1
  doi: 10.1002/1878-0261.12606
– ident: e_1_2_11_35_1
  doi: 10.3892/or.2022.8404
– ident: e_1_2_11_28_1
  doi: 10.1038/s41597-023-02074-6
– ident: e_1_2_11_44_1
  doi: 10.2147/CMAR.S200819
SSID ssj0036494
Score 2.4940677
Snippet Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor‐associated macrophages (TAMs) in...
Epithelial-mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in...
Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4521
SubjectTerms Cancer therapies
CD163 antigen
Cell proliferation
Cells
E-cadherin
Enzyme-linked immunosorbent assay
epithelial–mesenchymal transition
Growth factors
Homeobox
Immunohistochemistry
Leukocyte migration
Ligands
Lung cancer
Lung carcinoma
lung squamous cell carcinoma
Macrophages
Medical prognosis
Metastases
Metastasis
Monocytes
Nitric oxide
Original
Patients
Smad protein
Smad3 protein
Squamous cell carcinoma
Stroma
Transcription factors
Transforming growth factor-b
Transforming growth factor-b1
Tumors
tumor‐associated macrophage
Vascular endothelial growth factor
Vimentin
Western blotting
Zinc finger proteins
SummonAdditionalLinks – databaseName: Wiley Online Library - Core collection (SURFmarket)
  dbid: DR2
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEDZVD4gLlP-lBRnEgUvaJPYmsThVFVWFtBxokXpAisaJw66an2U3q_6c-ghIvAkPwkP0SZixs1GXgoQ4ZZOMN-N4PDOxZ-Zj7HWhDUgJ4KE4hZ7MhPBA5MqLBQwzkcgCbPrY6EN08Em-Px4er7G3y1wYVx-iX3CjmWH1NU1w0PNrk5wgwdAWJ5RJTrFa5BB97EtHiUgqB2grY0_5IuyqClEUT99y1RbdcDBvxkle91-tAdq_xz4vWXdxJyfbi1ZvZxe_VXX8z75tsLudY8p3nSTdZ2umfsBuj7qt94e3Nkbh1eW3cnJieLuomhmeQDe0JucVEBTYGJXTnE9thJ_hZkr5HiUK-NXl94qynLLxeYXPaMk-2lAx3sEE4dG4y-RDozXlX2bNaTvmDg6I__yxc1hBvnMxqTNe2JVIbpAD3ZxxPbGJOXzcVKahCwSyfArnnJaYOTagsHti0bRA6VOTjE-RvRpVW8mhzl13OO1gEOslxfpYccW2vERdyOdfF0ArJI4mI_SluqngETvaf3e0d-B1eBJeJiPUpdr4OjC-inUYxrECiMHPh0kRCzQXEkU2R32UJQrQaSlUERZ-oqPQaIGEQ6XFY7ZeN7V5yngYAxWqi7NIGkniXgyFAZ0UQU4ftWbA3iwFK826WusE-VGmy28uHOHUjvCAvepJp67AyJ-ItpbSmXY6Zp6GirbHpIrUgL3sb6N2oJcBtcH3khKaAZU3EvgXT5ww908RcYL-aRAMWLIi5j0BVR5fvVNPxrYCeeATqlngYz-tGP-d83Rv99D-ePbvpJvsToiupAsa2mLr7WxhnqPr1-oXdo7_AsQOY_M
  priority: 102
  providerName: Wiley-Blackwell
Title M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcas.15987
https://www.ncbi.nlm.nih.gov/pubmed/37806311
https://www.proquest.com/docview/2903094969
https://www.proquest.com/docview/2874837037
https://pubmed.ncbi.nlm.nih.gov/PMC10728010
Volume 114
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbhMxEDa0lRAcEP8ESmQQBy5WNraz3j2hUrWqkFJVbZFyW9leL4nYn7TZCMqJd-BNeBAegidhxuuEVgUuSbQ7u7G9386Mx-P5CHldGKel1JoBnDiTVgimRZ4yJfTIikQW2m8fGx_GBx_k-8loEgJui5BWudKJXlHnjcUY-YCnuBgg0zh9Oz9jyBqFq6uBQmODbGHpMkS1mqwnXCKWaUdqKxWDy3moLISZPEgoBpYcM-ku26NrTub1XMnLPqw3Qvv3yN3gPdKd7nHfJzdd_YDcGof18Yc37ow5K2efHG2XVXPOdBh7l9NKI1fXFLTHgs59Cp6jbo4bMkpA4K9v3yvchmSnFxXcv0UD5nO5aODxgW_XHUYnF8wd_Qjz93ZKO74e-vPH4KTS-eDrrLa08KFC6phpvlAz8_tm6LSpXIMHkAP5s76gGAGmII5Z8dhA12rc3TSzdA6Nq0HzlFTXedcVigsM2PASU3E8muBaWoKqoouzpcYARidjkRypbir9iJzu753uHrBA98CsjEHVGReZoYtSZThXKtVa6SgfJYUSoM0lICoHdWGTVINPUaQFL6LExNwZAYKj1IjHZLNuaveUUK401pFTNpZOIhqLkXDaJMUwxzmn65E3q2ee2VAKHRk5ymw1JQJ4ZB4ePfJqLTrv6n_8TWh7BZwsqIBF9gewPfJyfRpeXhwMXTsYlwzJBrD6kIBbPOlwtv4XoRJwH4fDHkmuIHAtgIXBr56pZ1NfIBym9Bw8jwj66cH675Znuzsn_sez_3fhObnNwbvr8ni2yWZ7vnQvwBtrTZ9scHnU9y9en2y92zs8Ou77yAZ-HvPfLd1C4A
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB1KkXgsEG8CBQYEUjejODMTPxYIVYUqpU03DVJ21ng8xhF-pImjEFb8A9_Bhg_hI_gS7h3boVWBXVeJ7BvnjufMfczcByEvk8goKZViACfOpBaCKREHzBOqr4UvE2XTx4ZH7uCDfD_ujzfI9zYXBsMqW5loBXVcatwj7_IADwNk4AZvpicMu0bh6WrbQqOGxYFZLcFlm7_efwvz-4rzvXej3QFrugowLV1YUZFxop5xAi_i3PMCpTzlxH0_8QQIDQmMx4BK7QcKVFcSJDxx_Mjl4HMCYT-IBDz2MrkCetdBX88br_074cqg7qErPQbc8qaQEQYOYf8yMBwwcO-0-jtn054PzTxtMludt3eL3GyMVbpTo-s22TDFHXJ12BzH3710Y8hZNvlkaLXIyxlTzVSbmOYKW4OlIKzmdGoj_gw1U8z_yADwv75-yzHrSaerHJ5fob60oWO0aRsEn6a-jDY1aFf6cVYuq5TW7YHozx_d41zF3S-TQtPE7kxSw6LyM40mNk2HpmVuSryALZeXakVxw5kCOQbhI4OmUphMNdF0CswVIOgyqoq4HgrF8wxkPMPIHwte-C3NQDLS-clC4X5JTaOxF1NR5uoeGV0EDu6TzaIszENCuaewbJ2nXWkkgj_pC6MiP-nF6OKaDtlu5zzUTeV1bACSha0HBvAILTw65MWadFqXG_kb0VYLnLCROPPwz_rokOfr2yAr8GWowsB7CbG3ARY7EvCIBzXO1v8iPB-s1V6vQ_wzCFwTYB3ys3eKSWrrkcNK4GDoODBOC9Z_cx7u7hzbL4_-P4Rn5NpgNDwMD_ePDh6T6xwMyzqEaItsVrOFeQKGYBU9tcuPkvCCl_tvRdB6AA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF5KKlVwQPwVAgUWBBKXVez1xmsfECpto5aSqKJF6s1a2-smqn_SxFEIJ96BN-HGS_AQPAkzazu0KnDrKZE9cXa9387M7s7MR8jLJNRKCKUYwIkzETkOU07sM-mobuR4IlEmfaw_cHc_iffH3eMV8qPJhcGwykYnGkUdFxHukXe4j4cBwnf9TlKHRRxs996OzxgySOFJa0OnUUFkXy_msHybvtnbhrF-xXlv52hrl9UMAywSLsyuUFuhrS1fhpxL6SsllRV3vUQ6oEAEdCIGhEaer8CMJX7CE8sLXQ7rTxDs-qEDj71OViUuilpk9d3O4OBjYwYcV_gVo66QDNrO67JGGEaEbGbgRmAY33ljeMnDvRyoed6BNhawd5vcql1Xullh7Q5Z0fldstavD-fvXbvZ5ywdnWpazrJiwlQ98DqmmUKisCGorikdm_g_TfUYs0FSgP-vr98yzIGKhosMnl-i9TSBZLQmEYJPXV1GDxtsLT2ZFPNySCuyIPrze-cwU3HnyyiPaGL2KalmYfGZhiOTtEOHRaYLvIAEzHO1oLj9TEEcQ_KxgbpUmFo1iugYGpeD2kupyuOqKxRPN7DhKcYBGSjDb2kKepJOz2YKd08qmQiZmfIiU_fJ0VUgYZ208iLXDwnlUmEROxm5QgucCknX0Sr0EjvGBa9uk9fNmAdRXYcd6UDSoFmPATwCA482ebEUHVfFR_4mtNEAJ6j1zzT4M1va5PnyNmgOfBkq1_BeAmQ6wNJHDjziQYWz5b840gPf1bbbxLuAwKUAViW_eCcfDU11cttCxjPbgn4asP675cHW5qH58uj_XXhG1mCqBx_2BvuPyQ0OXmYVT7RBWuVkpp-AV1iGT-v5R0lwxTP-N8hcf5s
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=M2-like+tumor-associated+macrophages+promote+epithelial%E2%80%93mesenchymal+transition+through+the+transforming+growth+factor+%CE%B2%2FSmad%2Fzinc+finger+e-box+binding+homeobox+pathway+with+increased+metastatic+potential+and+tumor+cell+proliferation+in+lung+squamous+cell+carcinoma&rft.jtitle=Cancer+science&rft.au=Sumitomo%2C+Ryota&rft.au=Menju%2C+Toshi&rft.au=Shimazu%2C+Yumeta&rft.au=Toyazaki%2C+Toshiya&rft.date=2023-12-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1347-9032&rft.eissn=1349-7006&rft.volume=114&rft.issue=12&rft.spage=4521&rft.epage=4534&rft_id=info:doi/10.1111%2Fcas.15987&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-9032&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-9032&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-9032&client=summon